CD38 polymorphisms in Spanish patients with systemic lupus erythematosus

Human Immunology
María Francisca González-EscribanoAntonio Núñez-Roldán

Abstract

The ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (CD38) gene is a positional and functional candidate gene for the susceptibility to systemic lupus erythematosus (SLE) because CD38 gene maps in the described SLE risk region 4p15 and CD38 molecule is a leukocyte activation antigen and ectoenzyme involved in numerous immune functions. The aim of this study was to investigate the possible association of the polymorphisms located at positions 182 of intron 1 (C/G) and 418 (C/T, located in exon 3) of the CD38 gene with the susceptibility and clinical features of SLE. Genotyping of 276 Spanish patients with SLE and 194 controls was performed by polymerase chain reaction amplification-refractory mutation system techniques. No association between the polymorphisms studied and the susceptibility to SLE was found. However, when patients were stratified according to their clinical manifestations, a significant increase of CC individuals and a significant decrease of CG individuals among patients with discoid rash (67.9% vs. 53.1% in controls p = 0.02, pc > 0.05, odds ratio [OR] = 1.87, 95% confidence interval [95% CI] 1.05-3.35; and 23.5% vs. 40.2% in controls, p = 0.008, pc = 0.024, OR = 0.46 95% CI 0.24-0.85) were found. Logistic reg...Continue Reading

References

Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Oct 1, 1995·Immunology Today·F LundM Howard
May 1, 1995·European Journal of Immunology·C M AusielloF Malavasi
Mar 1, 1995·The Journal of Experimental Medicine·M KumagaiD Campana
Mar 1, 1994·Immunology Today·F MalavasiK Mehta
Mar 21, 1998·The Journal of Clinical Investigation·S VidalA N Theofilopoulos
Dec 22, 1999·Scandinavian Journal of Immunology·A K Lindqvist, M E Alarcón-Riquelme
Mar 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·M T ZilberC Gelin
Jan 4, 2001·Leukemia Research·S DeaglioF Malavasi
Apr 3, 2001·International Immunology·R MalloneF Malavasi
Sep 25, 2001·Immunity·E K WakelandT W Behrens
Sep 7, 2002·Genes and Immunity·J A KellyJ B Harley
Jan 18, 2003·Drugs of Today·Sachiko HiroseHiroyuki Nishimura

❮ Previous
Next ❯

Citations

Sep 8, 2010·Seminars in Cancer Biology·Silvia DeaglioFabio Malavasi
Apr 12, 2008·Trends in Molecular Medicine·Silvia DeaglioFabio Malavasi
Jul 8, 2009·Annals of the New York Academy of Sciences·Richard P EbsteinNurit Yirmiya
Oct 4, 2007·Annals of the New York Academy of Sciences·Alessandra C L CervinoRobert W Hoffman
Apr 12, 2013·Cytometry. Part B, Clinical Cytometry·Valeria QuaronaFabio Malavasi
Jan 13, 2012·Molecular Genetics and Metabolism·Valeria PolzonettiValerio Napolioni
Jun 23, 2012·Leukemia Research·Iryna V AbramenkoIryna S Dyagil
Jul 26, 2018·Frontiers in Immunology·Stephanie A AmiciMireia Guerau-de-Arellano
Jul 28, 2020·Frontiers in Immunology·Colton J GarelliJillian M Richmond
Feb 26, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Krzysztof JamroziakTadeusz Robak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.